GENMAB
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
GENMAB
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
1999-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.genmab.com
Total Employee:
501+
Status:
Active
Contact:
+ 45 7020 2728
Email Addresses:
[email protected]
Total Funding:
204.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
GlaxoSmithKline
GlaxoSmithKline investment in Post-IPO Equity - Genmab
Index Ventures
Index Ventures investment in Venture Round - Genmab
LODH Immunology Fund
LODH Immunology Fund investment in Venture Round - Genmab
BankInvest Biomedical Venture
BankInvest Biomedical Venture investment in Venture Round - Genmab
Dansk Erhvervsinvestering
Dansk Erhvervsinvestering investment in Venture Round - Genmab
Apax Partners France
Apax Partners France investment in Venture Round - Genmab
BankInvest Biomedical Venture
BankInvest Biomedical Venture investment in Venture Round - Genmab
Dansk Erhvervsinvestering
Dansk Erhvervsinvestering investment in Venture Round - Genmab
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-07 | Bolt Biotherapeutics | Genmab investment in Post-IPO Equity - Bolt Biotherapeutics | 15 M USD |
Key Employee Changes
Official Site Inspections
http://www.genmab.com Semrush global rank: 1.66 M Semrush visits lastest month: 14.83 K
Unable to get host informations!!!
More informations about "Genmab"
About - Genmab
Learn about Genmabโs commitment to sustainability and the companyโs environmental, social and governance commitments and performance. Our Responsibility. Careers. Be part of the โฆSee details»
Genmab - Wikipedia
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. [7] The โฆSee details»
Genmab 25
Each and every one of us, regardless of where we sit in the organization is driven by our core purposes โ that our unstoppable team will improve the lives of patients through innovative and differentiated antibody therapeutics. ...See details»
Genmab US - Transforming the Future of Antibody-Based Cancer โฆ
Genmab is a biotech company that creates antibody-based treatments for cancer and other serious diseases. United States. Global; Japan; Investors; Company. Featured Making a โฆSee details»
Org Chart Genmab - The Official Board
The organizational chart of Genmab displays its 54 main executives including Jan Van de Winkel, Anthony Pagano and Brad Bailey. Toggle navigation The Official Board. Search. Search. โฆSee details»
Genmab - Crunchbase Company Profile & Funding
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop โฆSee details»
Genmab Global Reach: 70+ Nationalities, 2,200 Team Members, 4 โฆ
Join Genmab and be part of a diverse team of 2,200 members from 70+ nationalities, making a global impact in the field of healthcare. Genmab Global Reach: 70+ Nationalities, 2,200 Team โฆSee details»
Our Structure Enables Scientific Innovation | Genmab US
Genmab regularly partners with other life science companies, academic institutions, and research organizations to unlock new antibody approaches for treating cancer and other serious diseases. We work collaboratively with our โฆSee details»
ใใผใ | ใธใงใณใใๆ ชๅผไผ็คพ
Welcome to Genmab Home ็งใใกใธใงใณใใใฏใใใใใใฎไปใฎๆทฑๅปใช็ ใฎๆฒป็ใฎๅจใๆนใๆ นๆฌใใๅคใใใใใๆไฝๅป่ฌๅใฎ็ ็ฉถ้็บใซๆณจๅใใใฐใญใผใใซใซๅฑ้ใใใใคใชใใฏใใญใธใผไผๆฅญใงใใ ...See details»
TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of โฆ
12 hours ago With respect to the commercialization of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer, Genmab leads commercialization in Japan and all โฆSee details»
Genmab to Vigorously Defend Alleged Claims of Trade Secret ...
5 days ago Genmab categorically refutes allegations and will vigorously defend the company COPENHAGEN, Denmark; March 22, 2025 โ Genmab A/S (Nasdaq: GMAB) announced โฆSee details»
At a Glance - Genmab
Genmab aims to improve peopleโs lives with antibody therapeutics. Through next-generation technology platforms, transactional research and data sciences, it has created a pipeline โฆSee details»
Genmab, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 6, 2025 Explore Genmab, Inc. with its drug pipeline, therapeutic area, technology platform, 68 clinical trials, 127 news, and 12 literature, Disease Domain:Neoplasms, Hemic and โฆSee details»
Uniquely Focused on Antibody Science | Genmab US
Genmab is driving the next generation of antibody-based medicines to transform the lives of patients with cancer and other serious diseases. Patients are at the center of all we do. At โฆSee details»
Genmab Announces Initiation of Share Buy-Back Program
2 days ago Company Announcement. Repurchase of up to 2.2 million shares with a maximum aggregate total value of DKK 4.0 billion; Reduce the capital of Genmab and honor our โฆSee details»
Our Responsibility - Genmab
We are dedicated to further building a sustainable organization that meets those environmental, social and governance (ESG) criteria most relevant to our business, thereby creating long โฆSee details»
Putting Patients First In All We Do | Genmab US
At Genmab, we value the vital contributions of patient and professional organizations in shaping the healthcare landscape. Below are a few groups that provide spaces for patients and care โฆSee details»
Genmab to Vigorously Defend Alleged Claims of Trade Secret ...
5 days ago About Genmab Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with โฆSee details»
Genmab A/S (GMAB) Stock Price Today - WSJ - The Wall Street โฆ
View the latest Genmab A/S (GMAB) stock price, news, historical charts, analyst ratings and financial information from WSJ.See details»
Corporate Responsibility & Sustainability | Genmab
Genmab is committed to transparency of clinical trial research. We recognize the scientific and ethical value of sharing clinical trial information in a non-biased and timely manner to benefit โฆSee details»